Cost Effectiveness [qnco]    
Screening [hlca]    
Chronic hepatitis C [dsyn]    
UNITED STATES [geoa]    
HEPATITIS C VIRUS [virs]    
Chronic infection [dsyn]    
Blood [tisu]    
Bear [mamm]    
UNITED STATES [geoa]    
Increasing [ftcn]    
Source [fndg]    
Morbidity [qnco]    
Mortality [qnco]    
Ageing [orgf]    
Infected [fndg]    
Objective [inpr]    
Decision [menp]    
Models [inpr]    
Cost Effectiveness [qnco]    
Screening [hlca]    
Populations [qnco]    
HEPATITIS C VIRUS [virs]    
Risks [idcn]    
FIBROSIS [patf]    
Progression [patf]    
Methods [inpr]    
State transition [inpr]    
Screening [hlca]    
Asymptomatic [fndg]    
Community [geoa]    
Based [ftcn]    
UNITED STATES [geoa]    
base [inch]    
Gender [orga]    
MIXED [ftcn]    
ADULT [aggp]    
Prior [tmco]    
Knowledge [inpr]    
Hepatitis C virus status [clna]    
interventions [hlca]    
Screening [hlca]    
Guideline [inpr]    
Based [ftcn]    
treatment [ftcn]    
Screening [hlca]    
Effectiveness [qlco]    
Measured [qlco]    
Quality Adjusted Life Years [tmco]    
Costs [qnco]    
Measured [qlco]    
dollars [qnco]    
base [inch]    
MALE [orga]    
WHITE [popg]    
AFRICAN AMERICAN [popg]    
HISPANIC [popg]    
YEARS [tmco]    
Screening [hlca]    
Guideline [inpr]    
Based [ftcn]    
treatment [ftcn]    
DIRECT ACTING Antiviral agent [phsu]    
chronic Hepatitis C virus infection [dsyn]    
Costs [qnco]    
QALY [tmco]    
HEPATITIS C VIRUS [virs]    
UNITED STATES [geoa]    
Reported [inpr]    
Varies [inpr]    
Markedly [qlco]    
Patients [podg]    
Numbers [qnco]    
Types [qlco]    
Risk Factors [qnco]    
Marginal [spco]    
Cost Effectiveness [qnco]    
RATIO [qnco]    
Screening [hlca]    
Decreases [qlco]    
Increases [qnco]    
Marginal [spco]    
Cost Effectiveness [qnco]    
RATIO [qnco]    
Greater [qnco]    
Accepted [qlco]    
Willing [fndg]    
pay [qnco]    
THRESHOLD [qlco]    
QALY [tmco]    
considered [idcn]    
Highly [qlco]    
Cost Effectiveness [qnco]    
Conclusions [idcn]    
targeted screening [topp]    
Cost Effectiveness [qnco]    
HEPATITIS C VIRUS [virs]    
prospective [resa]    
Evaluation [hlca]    
Screening [hlca]    
Tool [mnob]    
Comparison [acty]    
Screening [hlca]    
strategies [menp]    
